These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 401228)

  • 1. Sodium retention in cirrhosis and ascites: effects of continuous peritoneovenous shunting.
    Wexler MJ; Levy M
    Surg Forum; 1978; 29():473-4. PubMed ID: 401228
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium retention in dogs with experimental cirrhosis following removal of ascites by continuous peritoneovenous shunting.
    Levy M; Wexler MJ; McCaffrey C
    J Lab Clin Med; 1979 Dec; 94(6):933-46. PubMed ID: 501214
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of sodium retention in early cirrhosis of the liver: evidence for vascular overfilling.
    Levy M
    Semin Liver Dis; 1994 Feb; 14(1):4-13. PubMed ID: 8016661
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.
    Levy M; Wexler MJ
    J Lab Clin Med; 1978 Mar; 91(3):520-36. PubMed ID: 627753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
    Blendis LM
    Isr J Med Sci; 1986 Feb; 22(2):78-80. PubMed ID: 3512475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and hemodynamic effects of the peritoneovenous shunt. II. Long-term effects.
    Greig PD; Blendis LM; Langer B; Taylor BR; Colapinto RF
    Gastroenterology; 1981 Jan; 80(1):119-25. PubMed ID: 7004991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma atriopeptin before and after peritoneojugular venous shunt for hepatogenic ascites.
    Witte CL; Martinez AP; Witte MH
    N Engl J Med; 1987 Feb; 316(8):487. PubMed ID: 2949154
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneovenous shunting restores atrial natriuretic factor responsiveness in refractory hepatic ascites.
    Tobe SW; Morali GA; Greig PD; Logan A; Blendis LM
    Gastroenterology; 1993 Jul; 105(1):202-7. PubMed ID: 8514035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis.
    Domenicali M; Caraceni P; Principe A; Pertosa AM; Ros J; Chieco P; Trevisani F; Jiménez W; Bernardi M
    J Hepatol; 2005 Jul; 43(1):92-7. PubMed ID: 15893844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G
    Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneovenous shunting in cirrhosis: its role in the management of refractory ascites in the 1990s.
    Wong F; Blendis L
    Am J Gastroenterol; 1995 Dec; 90(12):2086-9. PubMed ID: 8540491
    [No Abstract]   [Full Text] [Related]  

  • 14. Peritoneovenous shunting for cirrhotic versus malignant ascites.
    Kostroff KM; Ross DW; Davis JM
    Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascites in cirrhosis of the liver.
    Buhac I
    Gastroenterology; 1979 Jun; 76(6):1503. PubMed ID: 437449
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites.
    Wong F; Bomzon A; Allard J; Liu P; Blendis L
    Clin Sci (Lond); 1999 May; 96(5):467-74. PubMed ID: 10209078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
    Hillaire S; Labianca M; Smadja C; Grange D; Franco D
    Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.